Why the study?
Does insurance type (Medicaid/Medicare vs HMO/private) impact the receipt of guideline-recommended treatments and in-hospital mortality in patients with NSTE ACS?
Population
96,895 patients with non-ST-segment elevation acute coronary syndromes from 521 U.S. hospitals.
Comparison
Medicaid insurance coverage or Medicare… vs Health maintenance organization or private…
Design
Cohort
Follow-up
in-hospital
Authors
Loading...
May signal care disparities for younger Medicaid NSTE-ACS patients; leaves open whether insurance type causally affects outcomes.
Does insurance type (Medicaid/Medicare vs HMO/private) impact the receipt of guideline-recommended treatments and in-hospital mortality in patients with NSTE ACS?
Medicaid coverage in younger NSTE ACS patients is associated with lower use of evidence-based therapies and higher in-hospital mortality compared to private insurance, whereas Medicare coverage in older patients shows comparable outcomes to private insurance.
Calvin et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: